Search Results

Abcam today announced the appointment of Markus Lusser as President.

Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”).

Abcam plc, a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation, announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash.

CAMBRIDGE, England & WALTHAM, Mass.--( BUSINESS WIRE )-- Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today filed and mailed a scheme circular (the ‘Scheme Circular‘) in connection with the acquisition of Abcam by Danaher Corporation (NYSE: DHR) (‘Danaher’), announced on August 28, 2023 (the ‘Transaction’). Under the terms of the Transaction Agreement, Danaher will acquire all of the outstanding shares of Abc

Abcam plc, a global leader in the supply of life science research tools, announced that it has entered into a definitive agreement pursuant to which Danaher Corporation will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.

Abcam plc, a global leader in the supply of life science research tools, held an Extraordinary General Meeting of its shareholders that was convened following a requisition notice from Dr. Jonathan Milner dated May 30, 2023.

Abcam plc, a global leader in the supply of life science research tools, announced that leading independent proxy advisor Institutional Shareholder Services, recommended that Abcam shareholders vote “FOR” Danaher Corporation’s proposed acquisition of Abcam ahead of its shareholder meetings on November 6, 2023.

Abcam plc, a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation for $24.00 per share in cash, to be implemented by way of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006.

Abcam plc, a global leader in the supply of life science research tools, provides the following updates.

Abcam plc, a global leader in the supply of life science research tools, announces that, having listened to and extensively engaged with shareholders, the Board of Directors has unanimously decided to initiate a process to explore strategic alternatives for the Company.